img

Global Lacosamide Oral Solution Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lacosamide Oral Solution Market Research Report 2024

Lacosamide oral solution is indicated in patients 17 years and older with partial-onset seizures as adjunctive therapy. Lacosamide oral solution may be taken with or without food.
According to Mr Accuracy reports’s new survey, global Lacosamide Oral Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029.
Key manufacturers engaged in the Lacosamide Oral Solution industry include Jiangxi Kerui Pharmaceutical Co., Ltd., China Resources Double-crane Pharmaceutical Co., Ltd., Haida Shehuage Pharmaceutical Co., Ltd., Shanghai Aucta Pharmaceuticals Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Shandong Loncom Pharmaceutical Co., Ltd, Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited and Glenmark Pharma INC, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Lacosamide Oral Solution were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Lacosamide Oral Solution market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lacosamide Oral Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Jiangxi Kerui Pharmaceutical Co., Ltd.
China Resources Double-crane Pharmaceutical Co., Ltd.
Haida Shehuage Pharmaceutical Co., Ltd.
Shanghai Aucta Pharmaceuticals Co., Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
Shandong Loncom Pharmaceutical Co., Ltd
Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
UCB Pharma Limited
Glenmark Pharma INC
Vista Pharm INC
Segment by Type
Generic Drug
Original Drug

Segment by Application


Hospital
Retail Drug Store
Online Sales
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Lacosamide Oral Solution report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Lacosamide Oral Solution Market Overview
1.1 Product Overview and Scope of Lacosamide Oral Solution
1.2 Lacosamide Oral Solution Segment by Type
1.2.1 Global Lacosamide Oral Solution Market Value Comparison by Type (2024-2034)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Lacosamide Oral Solution Segment by Application
1.3.1 Global Lacosamide Oral Solution Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Retail Drug Store
1.3.4 Online Sales
1.3.5 Others
1.4 Global Lacosamide Oral Solution Market Size Estimates and Forecasts
1.4.1 Global Lacosamide Oral Solution Revenue 2018-2029
1.4.2 Global Lacosamide Oral Solution Sales 2018-2029
1.4.3 Global Lacosamide Oral Solution Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Lacosamide Oral Solution Market Competition by Manufacturers
2.1 Global Lacosamide Oral Solution Sales Market Share by Manufacturers (2018-2024)
2.2 Global Lacosamide Oral Solution Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Lacosamide Oral Solution Average Price by Manufacturers (2018-2024)
2.4 Global Lacosamide Oral Solution Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Lacosamide Oral Solution, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lacosamide Oral Solution, Product Type & Application
2.7 Lacosamide Oral Solution Market Competitive Situation and Trends
2.7.1 Lacosamide Oral Solution Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lacosamide Oral Solution Players Market Share by Revenue
2.7.3 Global Lacosamide Oral Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lacosamide Oral Solution Retrospective Market Scenario by Region
3.1 Global Lacosamide Oral Solution Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Lacosamide Oral Solution Global Lacosamide Oral Solution Sales by Region: 2018-2029
3.2.1 Global Lacosamide Oral Solution Sales by Region: 2018-2024
3.2.2 Global Lacosamide Oral Solution Sales by Region: 2024-2029
3.3 Global Lacosamide Oral Solution Global Lacosamide Oral Solution Revenue by Region: 2018-2029
3.3.1 Global Lacosamide Oral Solution Revenue by Region: 2018-2024
3.3.2 Global Lacosamide Oral Solution Revenue by Region: 2024-2029
3.4 North America Lacosamide Oral Solution Market Facts & Figures by Country
3.4.1 North America Lacosamide Oral Solution Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Lacosamide Oral Solution Sales by Country (2018-2029)
3.4.3 North America Lacosamide Oral Solution Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lacosamide Oral Solution Market Facts & Figures by Country
3.5.1 Europe Lacosamide Oral Solution Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Lacosamide Oral Solution Sales by Country (2018-2029)
3.5.3 Europe Lacosamide Oral Solution Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lacosamide Oral Solution Market Facts & Figures by Country
3.6.1 Asia Pacific Lacosamide Oral Solution Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Lacosamide Oral Solution Sales by Country (2018-2029)
3.6.3 Asia Pacific Lacosamide Oral Solution Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lacosamide Oral Solution Market Facts & Figures by Country
3.7.1 Latin America Lacosamide Oral Solution Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Lacosamide Oral Solution Sales by Country (2018-2029)
3.7.3 Latin America Lacosamide Oral Solution Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lacosamide Oral Solution Market Facts & Figures by Country
3.8.1 Middle East and Africa Lacosamide Oral Solution Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Lacosamide Oral Solution Sales by Country (2018-2029)
3.8.3 Middle East and Africa Lacosamide Oral Solution Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lacosamide Oral Solution Sales by Type (2018-2029)
4.1.1 Global Lacosamide Oral Solution Sales by Type (2018-2024)
4.1.2 Global Lacosamide Oral Solution Sales by Type (2024-2029)
4.1.3 Global Lacosamide Oral Solution Sales Market Share by Type (2018-2029)
4.2 Global Lacosamide Oral Solution Revenue by Type (2018-2029)
4.2.1 Global Lacosamide Oral Solution Revenue by Type (2018-2024)
4.2.2 Global Lacosamide Oral Solution Revenue by Type (2024-2029)
4.2.3 Global Lacosamide Oral Solution Revenue Market Share by Type (2018-2029)
4.3 Global Lacosamide Oral Solution Price by Type (2018-2029)
5 Segment by Application
5.1 Global Lacosamide Oral Solution Sales by Application (2018-2029)
5.1.1 Global Lacosamide Oral Solution Sales by Application (2018-2024)
5.1.2 Global Lacosamide Oral Solution Sales by Application (2024-2029)
5.1.3 Global Lacosamide Oral Solution Sales Market Share by Application (2018-2029)
5.2 Global Lacosamide Oral Solution Revenue by Application (2018-2029)
5.2.1 Global Lacosamide Oral Solution Revenue by Application (2018-2024)
5.2.2 Global Lacosamide Oral Solution Revenue by Application (2024-2029)
5.2.3 Global Lacosamide Oral Solution Revenue Market Share by Application (2018-2029)
5.3 Global Lacosamide Oral Solution Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Jiangxi Kerui Pharmaceutical Co., Ltd.
6.1.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Corporation Information
6.1.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.1.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 China Resources Double-crane Pharmaceutical Co., Ltd.
6.2.1 China Resources Double-crane Pharmaceutical Co., Ltd. Corporation Information
6.2.2 China Resources Double-crane Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.2.4 China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.2.5 China Resources Double-crane Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Haida Shehuage Pharmaceutical Co., Ltd.
6.3.1 Haida Shehuage Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Haida Shehuage Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.3.5 Haida Shehuage Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Shanghai Aucta Pharmaceuticals Co., Ltd.
6.4.1 Shanghai Aucta Pharmaceuticals Co., Ltd. Corporation Information
6.4.2 Shanghai Aucta Pharmaceuticals Co., Ltd. Description and Business Overview
6.4.3 Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.4.5 Shanghai Aucta Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.6 Shandong Loncom Pharmaceutical Co., Ltd
6.6.1 Shandong Loncom Pharmaceutical Co., Ltd Corporation Information
6.6.2 Shandong Loncom Pharmaceutical Co., Ltd Description and Business Overview
6.6.3 Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Product Portfolio
6.6.5 Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
6.7 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
6.6.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Corporation Information
6.6.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Description and Business Overview
6.6.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.7.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
6.8 UCB Pharma Limited
6.8.1 UCB Pharma Limited Corporation Information
6.8.2 UCB Pharma Limited Description and Business Overview
6.8.3 UCB Pharma Limited Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.8.4 UCB Pharma Limited Lacosamide Oral Solution Product Portfolio
6.8.5 UCB Pharma Limited Recent Developments/Updates
6.9 Glenmark Pharma INC
6.9.1 Glenmark Pharma INC Corporation Information
6.9.2 Glenmark Pharma INC Description and Business Overview
6.9.3 Glenmark Pharma INC Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Glenmark Pharma INC Lacosamide Oral Solution Product Portfolio
6.9.5 Glenmark Pharma INC Recent Developments/Updates
6.10 Vista Pharm INC
6.10.1 Vista Pharm INC Corporation Information
6.10.2 Vista Pharm INC Description and Business Overview
6.10.3 Vista Pharm INC Lacosamide Oral Solution Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Vista Pharm INC Lacosamide Oral Solution Product Portfolio
6.10.5 Vista Pharm INC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lacosamide Oral Solution Industry Chain Analysis
7.2 Lacosamide Oral Solution Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lacosamide Oral Solution Production Mode & Process
7.4 Lacosamide Oral Solution Sales and Marketing
7.4.1 Lacosamide Oral Solution Sales Channels
7.4.2 Lacosamide Oral Solution Distributors
7.5 Lacosamide Oral Solution Customers
8 Lacosamide Oral Solution Market Dynamics
8.1 Lacosamide Oral Solution Industry Trends
8.2 Lacosamide Oral Solution Market Drivers
8.3 Lacosamide Oral Solution Market Challenges
8.4 Lacosamide Oral Solution Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Lacosamide Oral Solution Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Lacosamide Oral Solution Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Lacosamide Oral Solution Market Competitive Situation by Manufacturers in 2022
Table 4. Global Lacosamide Oral Solution Sales (K Bottles) of Key Manufacturers (2018-2024)
Table 5. Global Lacosamide Oral Solution Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Lacosamide Oral Solution Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Lacosamide Oral Solution Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Lacosamide Oral Solution Average Price (US$/Bottle) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Lacosamide Oral Solution, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Lacosamide Oral Solution, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lacosamide Oral Solution, Product Type & Application
Table 12. Global Key Manufacturers of Lacosamide Oral Solution, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lacosamide Oral Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide Oral Solution as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lacosamide Oral Solution Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Lacosamide Oral Solution Sales by Region (2018-2024) & (K Bottles)
Table 18. Global Lacosamide Oral Solution Sales Market Share by Region (2018-2024)
Table 19. Global Lacosamide Oral Solution Sales by Region (2024-2029) & (K Bottles)
Table 20. Global Lacosamide Oral Solution Sales Market Share by Region (2024-2029)
Table 21. Global Lacosamide Oral Solution Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Lacosamide Oral Solution Revenue Market Share by Region (2018-2024)
Table 23. Global Lacosamide Oral Solution Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Lacosamide Oral Solution Revenue Market Share by Region (2024-2029)
Table 25. North America Lacosamide Oral Solution Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Lacosamide Oral Solution Sales by Country (2018-2024) & (K Bottles)
Table 27. North America Lacosamide Oral Solution Sales by Country (2024-2029) & (K Bottles)
Table 28. North America Lacosamide Oral Solution Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Lacosamide Oral Solution Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Lacosamide Oral Solution Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Lacosamide Oral Solution Sales by Country (2018-2024) & (K Bottles)
Table 32. Europe Lacosamide Oral Solution Sales by Country (2024-2029) & (K Bottles)
Table 33. Europe Lacosamide Oral Solution Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Lacosamide Oral Solution Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Lacosamide Oral Solution Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Lacosamide Oral Solution Sales by Region (2018-2024) & (K Bottles)
Table 37. Asia Pacific Lacosamide Oral Solution Sales by Region (2024-2029) & (K Bottles)
Table 38. Asia Pacific Lacosamide Oral Solution Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Lacosamide Oral Solution Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Lacosamide Oral Solution Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Lacosamide Oral Solution Sales by Country (2018-2024) & (K Bottles)
Table 42. Latin America Lacosamide Oral Solution Sales by Country (2024-2029) & (K Bottles)
Table 43. Latin America Lacosamide Oral Solution Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Lacosamide Oral Solution Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Lacosamide Oral Solution Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Lacosamide Oral Solution Sales by Country (2018-2024) & (K Bottles)
Table 47. Middle East & Africa Lacosamide Oral Solution Sales by Country (2024-2029) & (K Bottles)
Table 48. Middle East & Africa Lacosamide Oral Solution Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Lacosamide Oral Solution Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Lacosamide Oral Solution Sales (K Bottles) by Type (2018-2024)
Table 51. Global Lacosamide Oral Solution Sales (K Bottles) by Type (2024-2029)
Table 52. Global Lacosamide Oral Solution Sales Market Share by Type (2018-2024)
Table 53. Global Lacosamide Oral Solution Sales Market Share by Type (2024-2029)
Table 54. Global Lacosamide Oral Solution Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Lacosamide Oral Solution Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Lacosamide Oral Solution Revenue Market Share by Type (2018-2024)
Table 57. Global Lacosamide Oral Solution Revenue Market Share by Type (2024-2029)
Table 58. Global Lacosamide Oral Solution Price (US$/Bottle) by Type (2018-2024)
Table 59. Global Lacosamide Oral Solution Price (US$/Bottle) by Type (2024-2029)
Table 60. Global Lacosamide Oral Solution Sales (K Bottles) by Application (2018-2024)
Table 61. Global Lacosamide Oral Solution Sales (K Bottles) by Application (2024-2029)
Table 62. Global Lacosamide Oral Solution Sales Market Share by Application (2018-2024)
Table 63. Global Lacosamide Oral Solution Sales Market Share by Application (2024-2029)
Table 64. Global Lacosamide Oral Solution Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Lacosamide Oral Solution Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Lacosamide Oral Solution Revenue Market Share by Application (2018-2024)
Table 67. Global Lacosamide Oral Solution Revenue Market Share by Application (2024-2029)
Table 68. Global Lacosamide Oral Solution Price (US$/Bottle) by Application (2018-2024)
Table 69. Global Lacosamide Oral Solution Price (US$/Bottle) by Application (2024-2029)
Table 70. Jiangxi Kerui Pharmaceutical Co., Ltd. Corporation Information
Table 71. Jiangxi Kerui Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 73. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product
Table 74. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. China Resources Double-crane Pharmaceutical Co., Ltd. Corporation Information
Table 76. China Resources Double-crane Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 78. China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product
Table 79. China Resources Double-crane Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Haida Shehuage Pharmaceutical Co., Ltd. Corporation Information
Table 81. Haida Shehuage Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 83. Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product
Table 84. Haida Shehuage Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Shanghai Aucta Pharmaceuticals Co., Ltd. Corporation Information
Table 86. Shanghai Aucta Pharmaceuticals Co., Ltd. Description and Business Overview
Table 87. Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 88. Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Product
Table 89. Shanghai Aucta Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 90. Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 91. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 92. Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 93. Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Product
Table 94. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 95. Shandong Loncom Pharmaceutical Co., Ltd Corporation Information
Table 96. Shandong Loncom Pharmaceutical Co., Ltd Description and Business Overview
Table 97. Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 98. Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Product
Table 99. Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
Table 100. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Corporation Information
Table 101. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Description and Business Overview
Table 102. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 103. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Product
Table 104. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
Table 105. UCB Pharma Limited Corporation Information
Table 106. UCB Pharma Limited Description and Business Overview
Table 107. UCB Pharma Limited Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 108. UCB Pharma Limited Lacosamide Oral Solution Product
Table 109. UCB Pharma Limited Recent Developments/Updates
Table 110. Glenmark Pharma INC Corporation Information
Table 111. Glenmark Pharma INC Description and Business Overview
Table 112. Glenmark Pharma INC Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 113. Glenmark Pharma INC Lacosamide Oral Solution Product
Table 114. Glenmark Pharma INC Recent Developments/Updates
Table 115. Vista Pharm INC Corporation Information
Table 116. Vista Pharm INC Description and Business Overview
Table 117. Vista Pharm INC Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2024)
Table 118. Vista Pharm INC Lacosamide Oral Solution Product
Table 119. Vista Pharm INC Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Lacosamide Oral Solution Distributors List
Table 123. Lacosamide Oral Solution Customers List
Table 124. Lacosamide Oral Solution Market Trends
Table 125. Lacosamide Oral Solution Market Drivers
Table 126. Lacosamide Oral Solution Market Challenges
Table 127. Lacosamide Oral Solution Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lacosamide Oral Solution
Figure 2. Global Lacosamide Oral Solution Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Lacosamide Oral Solution Market Share by Type in 2022 & 2029
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Lacosamide Oral Solution Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Lacosamide Oral Solution Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Retail Drug Store
Figure 10. Online Sales
Figure 11. Others
Figure 12. Global Lacosamide Oral Solution Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Lacosamide Oral Solution Market Size (2018-2029) & (US$ Million)
Figure 14. Global Lacosamide Oral Solution Sales (2018-2029) & (K Bottles)
Figure 15. Global Lacosamide Oral Solution Average Price (US$/Bottle) & (2018-2029)
Figure 16. Lacosamide Oral Solution Report Years Considered
Figure 17. Lacosamide Oral Solution Sales Share by Manufacturers in 2022
Figure 18. Global Lacosamide Oral Solution Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Lacosamide Oral Solution Players: Market Share by Revenue in 2022
Figure 20. Lacosamide Oral Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Lacosamide Oral Solution Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Lacosamide Oral Solution Sales Market Share by Country (2018-2029)
Figure 23. North America Lacosamide Oral Solution Revenue Market Share by Country (2018-2029)
Figure 24. United States Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Lacosamide Oral Solution Sales Market Share by Country (2018-2029)
Figure 27. Europe Lacosamide Oral Solution Revenue Market Share by Country (2018-2029)
Figure 28. Germany Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Lacosamide Oral Solution Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Lacosamide Oral Solution Revenue Market Share by Region (2018-2029)
Figure 35. China Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Lacosamide Oral Solution Sales Market Share by Country (2018-2029)
Figure 43. Latin America Lacosamide Oral Solution Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Lacosamide Oral Solution Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Lacosamide Oral Solution Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Lacosamide Oral Solution Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Lacosamide Oral Solution by Type (2018-2029)
Figure 54. Global Revenue Market Share of Lacosamide Oral Solution by Type (2018-2029)
Figure 55. Global Lacosamide Oral Solution Price (US$/Bottle) by Type (2018-2029)
Figure 56. Global Sales Market Share of Lacosamide Oral Solution by Application (2018-2029)
Figure 57. Global Revenue Market Share of Lacosamide Oral Solution by Application (2018-2029)
Figure 58. Global Lacosamide Oral Solution Price (US$/Bottle) by Application (2018-2029)
Figure 59. Lacosamide Oral Solution Value Chain
Figure 60. Lacosamide Oral Solution Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed